This study was designed to isolate and analyze inhibitory peptides against angiotensin I-converting enzyme (ACE) from protease treated Royal Jelly (RJ) hydrolysate. We obtained the fractions which inhibited ACE from the RJ hydrolysate treated with protease N using octadecyl silica gel (ODS) and Superdex
TM-peptide 10/30 (GPC) colums. In ODS column chromatography, an ACE inhibitory fraction was recovered after elution with 10% ethanol in water. And from it the most active fraction was obtained through 3 step high performance liquid chromatographies. As a result, two different ACE inhibitory peptides were purified. On the other hand, the RJ hydrolysate was fractionated with Superdex
TM-peptide 10/30 GPC column chromatography to obtain di- and tri-peptide fractions which processed marked inhibitory activity against ACE. And we carried out another 2 or 3 step HPLC of the fraction, obtaining 4 different peptides. By analysis of these 6 peptides using an amino acid sequencer, we could obtain Ile-Tyr (IY), Val-Tyr (VY), Ile-Val-Tyr (IVY), Tyr-Tyr (YY), Ile-Phe (IF), and Lys-Ser (LS); IC
50 values for ACE inhibition were 0.008, 0.02, 0.018, 0.028, 0.034, and 1.55mg/m
l, respectively. Especially, IY, YY, and LS were isolated first time from the RJ. In conclusion, this study elucidated that novel ACE inhibitory peptides were contained in RJ hydrolysate, and these might play an important role in ability of the RJ hydrolysate to depress the blood pressure via ACE inhibition.
View full abstract